Chong, DLW; Shah, SA; Kutschenreuter, J; Cusman, R; Murugananden Pillai, M; Kirwan, DE; Gilman, RH; Friedland, JS
(2025)
Fever-Induced Heat Shock Protein-70 Regulates Macrophage IL-1β and IL-10 Secretion During Mycobacterium tuberculosis Infection.
European Journal of Immunology, 55 (7).
e51963.
ISSN 0014-2980
https://doi.org/10.1002/eji.202551963
SGUL Authors: Chong, Deborah Lia Wah
![]() |
PDF
Published Version
Available under License Creative Commons Attribution. Download (6MB) |
![]() |
Microsoft Word (.docx) (Supporting File 1)
Supporting information
Download (10MB) |
![]() |
PDF
Accepted Version
Available under License Creative Commons Attribution. Download (2MB) |
Abstract
Fever is a common clinical symptom in patients with tuberculosis (TB). During fever, heat-shock proteins (HSPs), such as HSP70, are expressed, which are molecular chaperones regulating protein folding and may also have immunomodulatory properties. How fever modulates immune responses during TB and by which mechanisms is unknown. In this study, we investigated the effects of fever, and specifically the role of HSP70, on Mycobacterium tuberculosis (Mtb)-induced macrophage inflammatory responses. Human monocyte-derived macrophages (MDM) were infected with Mtb at 37°C or 40°C to mimic febrile conditions. Fever suppresses Mtb-induced IL-1β and IL-10 gene expression and secretion from MDM, but enhances Mtb-induced HSP70 secretion and intracellular accumulation in MDM. Extracellular HSP70 and HSP70-expressing macrophages are abundant in granulomas in TB patient biopsies. HSP70 antagonism decreases Mtb-induced IL-1β secretion during febrile conditions but has no significant effect on IL-10 secretion. Pretreatment of MDM with recombinant HSP70 significantly increases Mtb-induced IL-1β at 37°C. Finally, extracellular HSP70 negatively regulates further HSP70 secretion from MDM during Mtb infection. Overall, fever and subsequent HSP70 expression modulates proinflammatory innate immune response in TB, which may have implications for the development of host-directed therapies.
Item Type: | Article | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Additional Information: | © 2025 The Author(s). European Journal of Immunology published by Wiley-VCH GmbH This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | |||||||||
SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) | |||||||||
Journal or Publication Title: | European Journal of Immunology | |||||||||
ISSN: | 0014-2980 | |||||||||
Publisher License: | Creative Commons: Attribution 4.0 | |||||||||
Projects: |
|
|||||||||
URI: | https://openaccess.sgul.ac.uk/id/eprint/117640 | |||||||||
Publisher's version: | https://doi.org/10.1002/eji.202551963 |
Statistics
Actions (login required)
![]() |
Edit Item |